D. S. Gurianov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
D. S. Gurianov has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
G. D. Telegeev
NAS of Ukraine
2 shared publications- Gennadiy D. Telegeev
Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150, Zabolotnogo Str., 03143 Kyiv, Ukraine
2 shared publications - Svitlana V. Antonenko
Institute of Molecular Biology and Genetics of Natl. Acad. Sci. of Ukraine, Ukraine, 03143, Kyiv, Akad. Zabolotnogo str., 150
2 shared publications - A. S. Matvieienko
Інститут молекулярної біології і генетики НАН України, Україна, 03143, м Київ, вул. Акад. Заболотного, 150; Київський національний університет технологій та дизайну, Україна, 01011, м. Київ, вул. Мала Шияновська, 2
1 shared publication - D. O. Nishchenko
NGO “Bioinformatics for Ukraine
1 shared publication S. V. Antonenko
Institute of Molecular Biology and Genetics, NAS of Ukraine
1 shared publication
Latest Publications
- Open Access
- 2 July 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 36, 69-74
Generation of recombinant constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2 as key tools for studying the domain organization of USP1 and its interaction with the oncoprotein Bcr-Abl
Aim. The aim of this study is to generate recombinant constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, essential for investigating the domain organization of the USP1 protein, determining their role in USP1 function, and analyzing their interaction with the oncoprotein Bcr-Abl. Methods. Standard molecular cloning techniques were employed, including polymerase chain reaction (PCR), ligation, restriction enzyme digestion, as well as DNA extraction and purification methods. Results. The genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, encoding key domains of the USP1 protein, were successfully designed and obtained. Conclusions. The generated genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2 will be utilized to study the role of these domains in USP1 function, its subcellular localization, and the formation of the Bcr-Abl/USP1 protein complex. These findings will contribute to a better understanding of the role of USP1 in cellular processes and facilitate the development of novel therapeutic approaches for the treatment of chronic myeloid leukemia (CML).
- 2 July 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 36, 69-74
Open AccessGeneration of recombinant constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2 as key tools for studying the domain organization of USP1 and its interaction with the oncoprotein Bcr-Abl
Aim. The aim of this study is to generate recombinant constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, essential for investigating the domain organization of the USP1 protein, determining their role in USP1 function, and analyzing their interaction with the oncoprotein Bcr-Abl. Methods. Standard molecular cloning techniques were employed, including polymerase chain reaction (PCR), ligation, restriction enzyme digestion, as well as DNA extraction and purification methods. Results. The genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2, encoding key domains of the USP1 protein, were successfully designed and obtained. Conclusions. The generated genetic constructs pECFP-C3-USP1-domain-1 and pECFP-C3-USP1-domain-2 will be utilized to study the role of these domains in USP1 function, its subcellular localization, and the formation of the Bcr-Abl/USP1 protein complex. These findings will contribute to a better understanding of the role of USP1 in cellular processes and facilitate the development of novel therapeutic approaches for the treatment of chronic myeloid leukemia (CML).
- Open Access
- 25 September 2024
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 34, 88-94
Features of Usp1 expression and localization in different types of malignant neoplasms
Aim. Malignant neoplasms pose a significant challenge in medicine, requiring a deep understanding of the molecular mechanisms underlying their pathogenesis. This study aimed to investigate the expression profile and subcellular localization of ubiquitin-specific protease 1 (USP1) in various types of cancer. Methods. Using the TCGA database, an analysis of USP1 expression was conducted across different cancer types. Immunofluorescence analysis with confocal microscopy was utilized to determine the subcellular localization of USP1 in chronic myeloid leukemia (CML) and prostate cancer cells. Results. Bioinformatic analysis revealed heterogeneous USP1 expression, with increased levels observed in acute myeloid leukemia, esophageal carcinoma, and glioblastoma multiforme. Immunofluorescence analysis confirmed nuclear localization of USP1 in CML cells and showed that inhibiting USP1 interaction with UAF1 using ML323 disrupts its transport to the nucleus. Prostate cancer cells exhibited both nuclear and atypical cytoplasmic USP1 localization, suggesting alterations in its expression, interaction with UAF1, and disruption of signaling pathways. Conclusions. USP1 plays a multifaceted role in cancer processes, with dysregulation of its expression and localization associated with tumorigenesis. Targeting USP1 holds therapeutic potential for cancer treatment.
- 25 September 2024
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 34, 88-94
Open AccessFeatures of Usp1 expression and localization in different types of malignant neoplasms
Aim. Malignant neoplasms pose a significant challenge in medicine, requiring a deep understanding of the molecular mechanisms underlying their pathogenesis. This study aimed to investigate the expression profile and subcellular localization of ubiquitin-specific protease 1 (USP1) in various types of cancer. Methods. Using the TCGA database, an analysis of USP1 expression was conducted across different cancer types. Immunofluorescence analysis with confocal microscopy was utilized to determine the subcellular localization of USP1 in chronic myeloid leukemia (CML) and prostate cancer cells. Results. Bioinformatic analysis revealed heterogeneous USP1 expression, with increased levels observed in acute myeloid leukemia, esophageal carcinoma, and glioblastoma multiforme. Immunofluorescence analysis confirmed nuclear localization of USP1 in CML cells and showed that inhibiting USP1 interaction with UAF1 using ML323 disrupts its transport to the nucleus. Prostate cancer cells exhibited both nuclear and atypical cytoplasmic USP1 localization, suggesting alterations in its expression, interaction with UAF1, and disruption of signaling pathways. Conclusions. USP1 plays a multifaceted role in cancer processes, with dysregulation of its expression and localization associated with tumorigenesis. Targeting USP1 holds therapeutic potential for cancer treatment.
- 1 October 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Fìzìologìâ roslin ì genetika
- Vol. 55 (5) , 395-416
Participation of autophagy in the response of plants to the action of abiotic stressors
- 1 October 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Fìzìologìâ roslin ì genetika
- Vol. 55 (5) , 395-416
Participation of autophagy in the response of plants to the action of abiotic stressors
- 1 September 2016
- Published by Allerton Press in Cytology and Genetics
- Vol. 50 (5) , 352-356
Colocalization of USP1 and РН domain of Bcr-Abl oncoprotein in terms of chronic myeloid leukemia cell rearrangements
- 1 September 2016
- Published by Allerton Press in Cytology and Genetics
- Vol. 50 (5) , 352-356
Colocalization of USP1 and РН domain of Bcr-Abl oncoprotein in terms of chronic myeloid leukemia cell rearrangements
- Open Access
- 29 February 2016
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 32 (1) , 26-33
Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling.
Chromosomal translocation t(9;22)(q34;q11) leads to the generation of different types of the BCR-ABL fusion protein and cause different types of leukemias. The generated fusion proteins differ by the presence or absence of certain domains of BCR – C2, PH, and DH. The mass-spectrometric analysis identified 23 possible interaction partners of PH domain of BCR. Among them is cortactin (CTTN), which is a multidomain protein responsible for the actin branching during endocytosis. The activation of cortactin occurs after phosphorylation by SRC kinase. However, it is unknown whether ABL kinase can phosphorylate and activate CTTN in the same manner. Aim. To demonstrate whether CTTN and PH domain of BCR colocalize in HEK293T cells, to analyze possible phosphorylation sites for ABL kinase in the cortactin and to make a comparative prediction for SRC kinase. Methods. Cells HEK293T were transfected with the engineered pECFP-C3-CTTN and pmCitrine-C1-PH using a cationic polymer transfection and evaluated with fluorescent microscopy. Putative phosphorylation sites of CTTN by ABL and SRC kinases were predicted by GPS 2.1 software. Results. PH domain and CTTN were expressed in HEK293T cells and show specific cellular colocalization. The phoshorylation sites for Abl kinase (Y384, Y396, Y409, Y416, Y427, Y433, and Y449) were detected in the proline-rich region of CTTN and they match corresponded sites predicted for SRC kinase. Conclusions. We have shown that CTTN has cytoplasmic localization and PH domain of BCR localized predominantly but not exclusively in the nucleus. Their partial colocalization occurs in specific dot-like perinuclear regions. A potential phosphorylation of CTTN by ABL may be one of the activation pathways during leukemogenesis.\u
- 29 February 2016
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 32 (1) , 26-33
Open AccessColocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling.
Chromosomal translocation t(9;22)(q34;q11) leads to the generation of different types of the BCR-ABL fusion protein and cause different types of leukemias. The generated fusion proteins differ by the presence or absence of certain domains of BCR – C2, PH, and DH. The mass-spectrometric analysis identified 23 possible interaction partners of PH domain of BCR. Among them is cortactin (CTTN), which is a multidomain protein responsible for the actin branching during endocytosis. The activation of cortactin occurs after phosphorylation by SRC kinase. However, it is unknown whether ABL kinase can phosphorylate and activate CTTN in the same manner. Aim. To demonstrate whether CTTN and PH domain of BCR colocalize in HEK293T cells, to analyze possible phosphorylation sites for ABL kinase in the cortactin and to make a comparative prediction for SRC kinase. Methods. Cells HEK293T were transfected with the engineered pECFP-C3-CTTN and pmCitrine-C1-PH using a cationic polymer transfection and evaluated with fluorescent microscopy. Putative phosphorylation sites of CTTN by ABL and SRC kinases were predicted by GPS 2.1 software. Results. PH domain and CTTN were expressed in HEK293T cells and show specific cellular colocalization. The phoshorylation sites for Abl kinase (Y384, Y396, Y409, Y416, Y427, Y433, and Y449) were detected in the proline-rich region of CTTN and they match corresponded sites predicted for SRC kinase. Conclusions. We have shown that CTTN has cytoplasmic localization and PH domain of BCR localized predominantly but not exclusively in the nucleus. Their partial colocalization occurs in specific dot-like perinuclear regions. A potential phosphorylation of CTTN by ABL may be one of the activation pathways during leukemogenesis.\u